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Using site-directed mutagenesis we have expressed 
in Escherichia coli three engineered calmodulins 
(CaM) containing deletions in the solvent-exposed re­
gion of the central helix. These are CaMA84, Glu-84 
removed; CaM A83-84, Glu-83 and Glu-84 removed; 
and CaM A81-84, Ser-81 through Glu-84 removed. 
The abilities of these proteins to activate skeletal mus­
cle myosin light chain kinase, plant NAD kinase, and 
bovine brain calcineurin activities were determined, 
as were their abilities to bind a synthetic peptide based 
on the calmodulin-binding domain of skeletal muscle 
myosin light chain kinase. Similar results were ob­
tained with all three deletion proteins. Vm values for 
enzymes activated by the deletion proteins are all 
within 10—20% of those values obtained with bacterial 
control calmodulin. Relative to bacterial control val­
ues, changes in K acl or K d values associated with the 
deletions are all less than an order of magnitude: K„ct 
values for NAD kinase and myosin light chain kinase 
are increased 5-7-fo ld , K d values for binding of the 
synthetic peptide are increased 4-7-fo ld , and K Bcl val­
ues for calcineurin are increased only 1-3-fold . In 
assays of NAD kinase and myosin light chain kinase 
activation some differences between bovine calmodulin 
and bacterial control calmodulin were observed. With 
NAD kinase, « values for the bacterial control pro­
tein are increased 4-fold relative to values for bovine 
calmodulin, and Vm values are increased by 50%; with  
myosin light chain kinase, K BCt values are increased 2­
fold and Vm values are decreased 10-15%  relative to 
those values obtained with bovine calmodulin. These 
differences between bacterial control and bovine cal­
modulins probably can be attributed to known differ­
ences in postranslational processing of calmodulin in 
bacterial and eucaryotic cells. No differences between 
bovine and control calmodulins were observed in as­
says of calcineurin activation or peptide binding. Our 
observations indicate that contacts w ith the deleted
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residues, Ser-81 through Glu-84, are not critical in the 
calmodulin-target complexes w e have evaluated. For­
mation of these calmodulin-target complexes also does 
not appear to be greatly affected by the global altera­
tions in the structure of calmodulin that are associated 
with the deletions. In models in which the central helix 
is maintained in the altered calmodulins, each deleted 
residue causes the two lobes of calmodulin to be twisted  
100° relative to one another and brought 1.5 A closer 
together. However, in assays of enzyme activation and 
peptide binding w e have observed little or no differ­
ence between CaMA84 and either CaMA83—84 or 
CaM A81-84. Given a requirement for both lobes of 
calmodulin in the calmodulin-target complex, then the 
central helix must bend in order to compensate for 
effects of the deletions on the relative position of the 
lobes. This suggests that bending of the central helix 
also can occur in the native calmodulin-target complex.
Calmodulin is found in all eucaryotic cells, where it regu­
lates in a Ca2+-dependent manner the activities of numerous 
cellular enzymes (Manalan and Klee, 1984). As seen in the 
crystal structure (Babu et ai, 1985; Kretsinger et ai, 1986), it 
is 65 A long, with an overall dumbbell shape. The lobes at 
each end of the dumbbell are both comprised of a pair of EF- 
hands. The most striking aspect of the structure is the 40 A 
central helix, which is shared by the two lobes. The central 
third of this helix, encompassing residues Arg-74 through 
Glu-84, bridges the lobes and is entirely exposed to solvent. 
As defined by Kretsinger and Nockolds (1973) and Kretsinger 
et ai (1986), the central helix of calmodulin contains the “F” 
helix of the second EF-hand domain in calmodulin on one 
side of the solvent-exposed region and the “E” helix of the 
third EF-hand domain on the other. The crystal structure 
indicates no interactions between the lobes, and various so­
lution studies also show no evidence of significant contacts 
between them (Andersson et ai, 1983; Heidorn and Trewhella, 
1988; Seaton et ai, 1985; Thulin et ai, 1984). However, a 
disulfide bridge can form between the lobes of an engineered 
calmodulin that contains cysteine substitutions at positions 3 
and 146, which are 37 A apart in the crystal structure (Per­
sechini and Kretsinger, 1988b). This indicates that in solution 
the central helix must be flexible, probably in the solvent- 
exposed region.
We are currently investigating structure-function relations 
in calmodulin and have focused on the role of the central 
helix. In assays of enzyme activation and peptide binding, we 

























that contain deletions of Glu-84, Glu-83 and Glu-84, or Ser- 
81 through Glu-84, all within the solvent-exposed region of 
the central helix. Relative to the control calmodulin, all the 
deletions have similar effects, which amount to increases of 
less than an order of magnitude in Kd or Xact values and 
changes of less than 20% in Vm values.
In addition to eliminating specific side chains, the deletions 
we have introduced would be expected to alter the relative 
position of two lobes, which are on either side of the deleted 
regions. Our results demonstrate that with the targets we have 
evaluated there is a notable lack of sensitivity to these changes 
in the structure of calmodulin. This result is consistent with 
the model calmodulin-target complex proposed by Persechini 
and Kretsinger (1988a, 1988b), in which the solvent-exposed 
region in the central helix of calmodulin functions as a flexible 
tether, and most contacts are between residues of the target 
and those in the lobes of calmodulin.
EXPERIMENTAL PROCEDURES
Preparation of Proteins—Myosin light chain kinase was isolated 
from rabbit skeletal muscle as described by Takio et al. (1985), 
calcineurin was isolated from bovine brain as described by Klee et al.
(1983), and NAD kinase was isolated from pea seedlings as described 
by Harmon et al. (1984). Calmodulins expressed in Escherichia coli 
were isolated essentially as described by Craig et al. (1987). The 
following procedure is for a liter of bacterial culture. 50 ml of media 
(Bacto-yeast tryptone, 16 g/liter; Bacto-yeast extract, 10 g/liter; and 
NaCl 5 g/liter; final pH 7.5) containing 25 Mg/ml ampicillin is inoc­
ulated with a scrape from a frozen stock of bacteria transformed with 
the desired calmodulin-encoding pKK233-2 construction. Details of 
cloning procedures are discussed under “Site-directed Mutagenesis.” 
After growth overnight at 37 °C, 25 ml of this culture is used to 
inoculate a liter of fresh media at 37 °C. After the OD550 of this fresh 
culture has reached a value of 0.3, 300 mM isopropyl-/3-D-thiogalac- 
toside is added to a final concentration of 1 mM, followed by growth 
for an additional 3 h. Bacterial cells are collected by centrifugation 
at 4 °C and 2500 x  g, resuspended in 200 ml of ice-cold 50 mM Tris- 
HC1, pH 7.5, and resedimented at 2500 x g. Pelleted cells are sus­
pended in 50 ml of ice-cold lysis buffer that contains 50 mM Tris- 
HC1, pH 7.5, 2 mM EDTA, and 1 mM DTT .1 Egg white lysozyme is 
then added to a final concentration of 200 pg/ml, followed by incu­
bation on ice for 40 min. The bacterial lysate is sonicated with a 
Branson probe sonicator at a power setting of 70 watts, until the 
viscosity has dropped sufficiently to allow subsequent handling. Cel­
lular debris is sedimented by centrifugation at 27,000 X g for 20 min. 
The supernatant fraction is removed, and CaCl2 is added to a final 
concentration of 5 mM. 3 ml of phenyl-Sepharose equilibrated with 
buffer A (50 mM Tris-HCl, pH 7.5, 0.5 mM DTT, and 0.1 mM CaCl2) 
is then added. This mixture is stirred at room temperature for 40 min 
and washed twice with 10-20 volumes of buffer A. The resin is poured 
into a column and washed further with buffer A at a flow rate of 50 
ml/h until the eluate has an absorbance at 280 nm of less than 0.04. 
The resin is then washed with buffer A plus 0.5 M NaCl until the 
absorbance of the eluate is undetectable. Bound calmodulin is eluted 
with a buffer containing 0.15 M NaCl, 50 mM Tris-HCl, pH 7.5, 0.5 
mM DTT, and 1 mM EDTA. Inclusion of NaCl inhibits elution of 
two minor high molecular weight contaminants. All chromatography 
procedures are performed at room temperature. Purity of eluted 
material is characterized by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis with a protein load of 15 ng followed by Coomassie 
Blue staining. If protein bands other than calmodulin are detected, a 
second step of phenyl-Sepharose chromatography is performed. After 
this second step calmodulins are always electrophoretically homoge­
neous. Pooled calmodulin fractions are dialyzed exhaustively against 
10 mM ammonium bicarbonate and stored frozen at -80  °C. We 
typically obtain 2-3 mg of pure calmodulin/liter of bacterial culture. 
Protein concentrations were determined by the Bradford (1976) dye 
binding assay using a bovine serum albumin protein standard. Cal­
1 The abbreviations used are: DTT, dithiothreitol; CaM, calmodu­
lin; CaMA84, an engineered calmodulin in which Glu-84 has been 
deleted; CaMA83-84, Glu-83 and Glu-84 deleted; CaMA81-84, Ser-
81 through Glu-84 deleted; EGTA, [ethylenebis(oxyethylenenitrilo)] 
tetraacetic acid; MOPS, 4-morpholinepropanesulfonic acid.
modulin concentrations were determined from the absorbance at 280 
nm using an E° l% = 0.21 and/or from amino acid compositions. 
Values determined by these two methods agree to within 5%. Amino 
acid compositions were determined as described by Jarrett et al. 
(1986), or as described by Bidlingmeyer et al. (1984), and Heinrickson 
and Meredith (1984). N-terminal analysis was performed essentially 
as described by Hewick et al. (1981) and Hunkapillar et al. (1984) 
with an Applied Biosystems 470A protein sequencer. Sodium dodecyl 
sulfate gel electrophoresis was performed using 15% polyacrylamide 
slabs as described by Laemmli (1970). Urea gel electrophoresis was 
performed in the presence of 0.1 mM CaCl2 as described by Persechini 
et al. (1986). Sample mixtures contained 6 M urea, 100 mM Tris-HCl, 
pH 7.4, 0.1 mM added CaCl2, and various amounts of added calmo­
dulin and melittin (Sigma). Melittin concentrations were calculated 
from the absorbance at 280 nm, using the extinction coefficient for 
tryptophan.
Enzyme Assays—Myosin light chain kinase was assayed essentially 
as described by Blumenthal and Stull (1980), except that a synthetic 
peptide substrate, KKRPQRATSNYFS-amide, was used instead of 
mixed myosin light chains. Each reaction mixture contained 0.5 mM 
peptide substrate, 50 mM MOPS, pH 7.0, 100 CaCl2, 4 nM rabbit 
skeletal muscle myosin light chain kinase, 0.35 mM [y-32P]ATP (160— 
300 cpm/pmol), and the indicated total concentrations of calmodulin. 
Reactions were terminated by applying a 20-#il aliquot to P-81 filter 
paper followed by immersion in 75 mM phosphoric acid. Subsequent 
processing of samples was performed as described by Roskowski
(1983). Values for K,a and Vm were determined by fitting enzyme 
activation data to a form of the true rate equation (Cha, 1970) with 
a Marquardt-Levenberg algorithm for a weighted nonlinear parame­
ter estimation using MathView Professional (BrainPower Inc.) soft­
ware run on a Macintosh computer.
Calcineurin was assayed essentially as described by Manalan and 
Klee (1983), except that a phosphorylated synthetic peptide was used 
as substrate. The peptide, which represents a phosphorylation site on 
the regulatory subunit of cAMP-dependent protein kinase (Blumen­
thal et al., 1986), was obtained from Peninsula and purified by high 
performance liquid chromatography on a C-18 column with a gradient 
of CH3CN in 0.1% trifluoroacetic acid. Assays were performed at 
30 °C for 25 min. Assay mixtures contained 20 mM Tris-HCl, pH 8.0, 
0.1 M NaCl, 0.5 mM DTT, 6 mM MgCl2, 0.1 mM CaCl2, 0.1 mg/ml 
bovine serum albumin, 5 nM calcineurin, and 0.34 11M  32P-phospho- 
rylated peptide (3600 cpm/pmol). Values for Kact and Vm were deter­
mined from the best fit of the data by a nonlinear regression analysis 
to a rate equation derived by Richards and Vithayathil (1959).
Plant NAD kinase was assayed as described by Harmon et al.
(1984). Assays contained 0.29 fig/ml of enzyme and various amounts 
of added calmodulin. Typically, 13 dilutions of each calmodulin, 
spanning at least a 100-fold range in concentration, were prepared 
and assayed. Data for enzyme activation were fit by a nonlinear least 
squares analysis to the Michaelis-Menten equation, as described 
previously (Harmon et al., 1984).
Fluorescence Measurements—Fluorescence anisotropy data were 
measured using an SLM 8000C spectrofluorometer in a “T” configu­
ration. The sample was excited at 370 nm (16 nm bandwidth), and 
emitted light was passed through Schott KV470 filters. The mono­
chromator of the A channel (vertically polarized) was “removed” by 
setting it to 0 nm (16 nm slits), whereas the B channel (horizontally 
polarized) had no monochromator in the light path. Anisotropy values 
were calculated with an on-line IBM PC using a single-point aniso­
tropy program provided by SLM. Each calmodulin titration experi­
ment was performed at 30 °C in a thermostatted 1 -cm cuvette con­
taining 3 M guanidine HC1, 50 mM MOPS, pH 7.0, 1 mM CaCl2, and
6 nM acrylodan-labeled synthetic peptide. Fluorescence emission 
spectra were collected with the SLM 8000C in ratio mode and the 
emission monochromator set at 370 nm (8 nm slits). The emission 
monochromator was scanned between 400 and 600 nm at 2-nm 
intervals (2 s/data point). The synthetic peptide, KRRWKKAFIAV- 
SAAARFKKC, is based on the calmodulin-binding domain of skeletal 
muscle myosin light chain kinase (Blumenthal et al., 1985). It was 
labeled by overnight reaction with a 2-fold molar excess of acrylodan 
(Molecular Probes, Inc.) at room temperature in 20% acetonitrile, 
80% H20  (v/v), 5 mM MOPS, pH 7.0. Labeled peptide was purified 
by reversed-phase high performance liquid chromatography. The 
molar extinction coefficient measured at 365 nm indicated that 1 mol 
of reagent was incorporated/mol of labeled peptide.
Fluorescence anisotropy data were analyzed to determine Kd values 
of peptide binding to calmodulin by using weighted nonlinear param­
























techniques gave estimates of Kd that were in good agreement with 
each other. Equations relating observed anisotropies to fractional 
saturations are based on the original derivations of Evett and Isenberg 
(1969) and Weber (1952). In the case of the nonlinear curve-fitting 




foba (Z(rmax "I" Tmin)/(l Z)
Z  = (Fmax/Fmi„)/{1/((1/Y) — 1)|
Y = {Kd + [CaM] ((Kd + [CaM] tot [peptidejtot)
-  4[CaM]tot[peptide],ot)05i/2[peptideJto,
The expression for Y, the fraction of calmodulin bound to the peptide, 
is in the form of the “true-rate” equation (Cha, 1970). The Marquardt- 
Levenberg algorithm for nonlinear parameter estimation included in 
the Math View Professional (BrainPower, Inc.) software package for 
the Macintosh computer was used for fitting. Each mean value of 
observed anisotropy (rob») was weighted using the standard deviation 
determined for that set of observations. For Scatchard analysis, the 
concentration of bound calmodulin, B, was calculated using the 
expression:
B — [peptide]tot/{(Fm„/Fm\n)((rmm ■ robs)/{^ *obs *^min)) 1} 
and the concentration of free calmodulin, F, calculated as:
F  = [CaM]tot — B
The Kd value for each calmodulin titration was determined from the 
slopes of Scatchard plots (B versus B /F ) after fitting the data to a 
line using unweighted least squares linear regression analysis. The 
value of rm„, the anisotropy observed at saturating concentrations of 
a given calmodulin, was calculated from the mean of the r1Jh, values 
taken at calmodulin concentrations in excess of 200 nM; these values 
were: 0.1488 (bovine); 0.1474 (control); 0.1437 (CaMA84); 0.1339 
(CaMA83-84); 0.1325 (CaMA81-84). The value of rmm, the anisotropy 
of the peptide in the absence of calmodulin, used in all calculations 
was 0.0827. The value of Fm,x/Fmi„, the ratio of the fluorescence 
intensity of the calmodulin-bound peptide relative to that of the free 
peptide, was determined using bovine calmodulin under instrument 
conditions identical to those described above for the anisotropy 
measurements. These particular measurements were made by setting 
the excitation polarizer to vertical and the emission polarizer to 54.7°, 
in order to eliminate polarization effects on fluorescence intensity. 
After correcting for blank, the value of Fma*/Fmi„ was determined to 
be 1 .68. Since the emission spectra for all the calmodulin-peptide 
complexes used in this study were virtually identical, this value for 
F,„„/Fml„ was used for all calculations. The terms [CaM]tot and 
[peptide]tot represent the total concentrations of calmodulin and 
acrylodan peptide, respectively.
Site-directed Mutagenesis—A partial calmodulin-encoding cDNA 
was isolated from an Arbacia punctulata Agtll library as described by 
Hardy etal. (1988). Site-directed mutagenesis was performed to create 
an iVcoI site at the natural ATG start codon and a missing region, 
encoding the last seven amino acids, was produced synthetically. The 
sequence of the final M13mpl8 (Norrander et al., 1983) clone is 
shown in Fig. 1. Some 5'-untranslated sequence is maintained in this 
clone. A protein identical to vetebrate calmodulin is encoded. Site- 
directed changes in the calmodulin-encoding sequence were intro­
duced using mismatched primer extension mutagenesis of M13mpl8 
single-stranded DNA as described by Zoller and Smith (1983), except 
duplex DNA was not enriched after in vitro primer extension. The 
lengths of mismatched primers were between 21 and 23 bases, with 
mismatches located in approximately the center of the primer. Phage 
containing the desired changes were identified by differential hybrid­
ization, using the [7 -32P]ATP-phosphorylated mismatched primer as 
a probe, and plaque-purified (Watterson et al., 1980). For expression 
experiments, desired calmodulin-encoding sequences were excised 
from M13mpl8 plasmid by cleaving with iVcoI and P stl restriction 
endonucleases. The resulting fragments were cloned in the expression 
vector pKK233-2 (Pharmacia LKB Biotechnology, Inc.) opened by 
JVcoI and P stl restriction digestion. Stocks of bacteria transformed 
with calmodulin expression vectors were grown from isolated ampi- 
cillin-resistant colonies and stored in 40% glycerol at —80 °C. All
calmodulin-encoding cDNAs were sequenced (Biggin et a l, 1981; 
Sanger and Coulsen, 1978) in their entirety before being expressed. 
Routine cloning procedures were performed as described by Maniatis 
et al. (1982). E. coli JM101 was the host strain used for all procedures.
Molecular Modeling—Molecular modeling was performed with the 
calmodulin coordinates available in our laboratory, where the crystal 
structure is currently undergoing refinement. The UCSD Molecular 
Modeling System run on an Iris 4040 was used to display and 
manipulate structures.
RESULTS
Modified and Control Bacterial Calmodulins—The sequence 
of the cDNA template encoding control bacterial calmodulin 
is presented in Fig. 1. Using primer-extension mutagenesis 
techniques (Zoller and Smith, 1983), we made three deletions 
in the region of the template encoding residues 81-84. The 
encoded deletion proteins are termed CaMA84, Glu-84 de­
leted; CaMA83-84, GIu-83 and Glu-84 deleted; and CaMA81- 
84, Ser-81 through Glu-84 deleted. The identity of bacterially 
expressed proteins was confirmed by amino acid analysis 
(data not shown). An unblocked alanine was found at the N 
terminus of the bacterial protein, in agreement with the 
results of Putkey et al. (1985) and Roberts et al. (1985). This 
is different from the bovine protein, in which the N terminus 
is acetylated (Watterson et al. 1980). It has been shown that 
calmodulin expressed in E. coli lacks trimethyllysine, which
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F ig . 1. The sequence of calmodulin-encoding cDNA cloned 
in M 13m pl8. X m nl and P stl ends were used to clone this sequence 
into an M13mpl8 vector cut with Smal and Pstl restriction endo­
nucleases. The 3'-terminat P stl site is indicated in the figure. The 
Ncol site used to clone the calmodulin-encoding segment into a 
pKK233-2 expression vector is also indicated. The ATG translation 
start and TGA translation stop sites are shown in boldface. The 
calmodulin sequence is shown above the DNA sequence encoding it. 
The sequence encoding residues Ser-81 through Glu-84 is also shown 
in boldface. Deletions in this region result in the following new 
sequences: GACAGCGAAGAGATC, CaMA84; GACAGCGAA- 
ATC, CaMA83-84; GATATC, CaMA81-84. Note that the sequence 
encoding Asp-80 in CaMA81-84 has been changed from GAC to GAT, 
















Deletions in the Calmodulin Central Helix 8055
is found in the native protein at position 115 (Putkey et al, 
1985; Roberts et al, 1985). We have not determined the 
trimethyllysine content in our calmodulin preparations, but 
assume that Lys-115 is not methylated.
The electrophoretic mobilities on urea polyacrylamide gels 
of bovine and bacterial calmodulins in the presence and 
absence of melittin are seen in Fig. 2. Melittin and related 
peptides are known to form a complex with calmodulin that 
is stable in urea and has an electrophoretic mobility that is 
slower than that of the uncomplexed protein (Comte et al, 
1983). In the absence of melittin a small progressive decrease 
in relative mobility is seen with the deletion proteins; this 
appears to be proportional to the number of deleted glutamic 
acid residues. With the more slowly migrating calmodulin- 
melittin complexes the effects of the deletions on relative 
mobilities are more pronounced. These differences in electro­
phoretic mobilities among the bacterial calmodulins are prob­
ably due to the loss of negative charge associated with succes­
sive deletions of glutamic acid. They are probably enhanced 
in the complex with a basic melittin peptide because of charge 
neutralization. A slightly decreased mobility relative to bovine 
calmodulin is seen with the control bacterial protein. This is 
probably due to the lack of acetylation at the N terminus 
and/or trimethylation of Lys-115. On sodium dodecyl sulfate 
polyacrylamide gels the electrophoretic mobilities of bovine 
calmodulin and the bacterial control and deletion proteins are 
not significantly different (not shown).
Enzyme Activation—The abilities of bovine and bacterial 
calmodulins to elevate skeletal muscle myosin light chain 
kinase, pea seedling NAD kinase, and bovine brain calcineurin 
activities were compared. Data for enzyme activation by the 
bacterial calmodulins are seen in Figs. 3 and 4. Typical values 
for Kact, the concentration of calmodulin giving half-maximal 
activation, and Vm are presented in Table I. For each of the 
enzyme activities assayed, all three deletion proteins have 
similar activation kinetics, which differ from what is observed 
with bacterial control calmodulin. With plant NAD kinase 
and myosin light chain kinase, Kacl values are increased 5-7­
fold relative to the bacterial control. With these two enzymes, 
a trend toward a reduced Vm value appears to be associated 
with increasing deletion size. These changes in Vm values are 
10% or less, and we have not yet established their significance. 
Kact values for activation of calcineurin by the deletion pro­
teins are 2-3-fold greater than bacterial control values, and 
Vm values are consistently 15-20% lower. As seen in Fig. 3A,
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Fig. 3. Activation of (.A) skeletal muscle myosin light chain 
kinase and (B) p lant NAD kinase activities by control and 
deletion calmodulins. Kinase activity is expressed as a fraction of 
the maximal level attained with the bacterial control. The indicated 
calmodulin concentrations are the total amounts added to the assay 
mixtures. In assays of myosin light chain kinase activity, concentra­
tions of synthetic peptide substrate and enzyme were 0.5 mM and 4 
nM, respectively. Plant NAD kinase assay mixtures contained 0.29 
Mg/ml enzyme. X, control; O, CaMA84; ■, CaMA83-84; □, CaMA81- 
84.
F ig . 2. The effect of m elittin on the electrophoretic mobili­
ties of bovine, control, and deletion calmodulins in u rea poly­
acrylam ide gels. Samples were prepared as described under “Ex­
perimental Procedures” in the presence (+) and absence (—) of added 
melittin. For bovine calmodulin, electrophoresis was performed only 
in the presence of melittin at a molar ratio to calmodulin of 0.4. For 
the bacterial calmodulins mellitin was added in a molar ratio of 0.7 
to 0.9 with respect to calmodulin, so in some + lanes protein bands 
corresponding to both free calmodulin and the calmodulin-melittin 
complex are visible. Bov, bovine calmodulin; Con, bacterial control; 
A84, CaMA84; A83-84, CaMA83-84; A81-84, CaMA81-84.
Calmodulin/Calcineurin
F ig . 4. Activation of bovine brain  calcineurin by control 
and deletion calmodulins. Fractional activity is expressed relative 
to the maximal level of activation obtained with the bacterial control 
calmodulin. The ratio, calmodulin/calcineurin, is the molar ratio of 
added calmodulin to calcineurin in the assay mixture. Concentrations 
of phosphorylated peptide substrate and calcineurin were 0.34 
























Steady state kinetic parameters for activation of various calmodulin- 
dependent enzymes by bovine, control, and deletion calmodulins 
Vm values are expressed as a fraction of the Vm value determined 
with bovine calmodulin. Kta is the concentration of calmodulin 
required for half-maximal enzyme activation. Values for K„a and Vm 
were estimated from enzyme kinetic data as described under “Exper­
imental Procedures.” For all three enzyme activities, Vm values de­
termined from duplicate data sets were seen to vary by less than 10%. 
Duplicate determinations of K,a values for myosin light chain kinase 
and plant NAD kinase were within a factor of two; calcineurin KHct 
values are ± 50%.
Calmodulin Vm (fractional)
nM



















Fig. 5. Fluorescence emission spectra for aerylodan-labeled 
peptide in the presence and absence of a saturating level of 
bovine calmodulin. Samples were excited at a wavelength of 370 
nm, and emission spectra were measured as described under “Exper­
imental Procedures.” Added bovine calmodulin (CaM) was 10-fold in 
excess over the 20 nM peptide concentration. The apparent emission 
spectrum for buffer alone is also shown in the figure. All spectra are 
uncorrected.
curves for myosin light chain kinase activation by the deletion 
proteins are all somewhat steeper than the curve for activation 
by the bacterial control. The reason for this difference is not 
known.
There are no apparent differences between bovine and 
control bacterial calmodulins with regard to calcineurin acti­
vation, but differences are seen with the other two enzymes. 
With NAD kinase K„a values for the bacterial control are 
increased 4-fold relative to values for bovine calmodulin, and 
Vm values are increased by 50-80%. With myosin light chain 
kinase there is a 2-fold increase in Kect values and a consistent 
10-15% reduction in Vm values. Roberts et al. (1985) have 
also reported an increase in Vm values for activation of NAD 
kinase by bacterial calmodulin. They attribute this to the lack 
of methylation at Lys-115 in the bacterial protein (Roberts et 
al., 1985). The other smaller differences between bacterial 
control and bovine calmodulins that we report here probably 
are also due to the lack of trimethyllysine-115 and/or N- 
acetylation in the bacterial proteins.
Peptide Binding—We have synthesized a peptide based on 
the calmodulin-binding domain of skeletal muscle myosin 
light chain kinase (Blumenthal et al., 1985). This peptide has 
the sequence: IC-R-R-W-K-K-A-F-I-A^-V-S-A-A-A-R-F-K- 
K-C20. We have stoichiometrically labeled Cys-20 with a flu­
orescent molecule, acrylodan, as described under “Experimen­
tal Procedures.” We have evaluated by fluorescence spectros­
copy the complexes between labeled peptide and bovine or 
the various bacterial calmodulins. No significant differences 
were observed in the acrylodan fluorescence emission spectra 
of the various complexes, whose maxima range from 504 to 
508 nm. Typical uncorrected emission spectra for peptides in 
the presence and absence of saturating bovine calmodulin are 
presented in Fig. 5. We have estimated Kd values for the 
calmodulin-peptide complexes by monitoring calmodulin-de­
pendent changes in acrylodan fluorescence anisotropy. Mean 
values (10 determinations per data point) for acrylodan fluo-
Calmodulin (nM)
Fig . 6. Acrylodan-labeled peptide fluorescence anisotropy 
measured at various concentrations of added bovine or bac­
terial calmodulins. Each point represents the mean of 10 determi­
nations. Standard deviations for the CaMA81-84 data set are also 
shown. Samples were excited at 370 nm, and the peptide concentra­
tion in each experiment was 6 nM. Further experimental details are 
presented under “Experimental Procedures.” • ,  bovine calmodulin; 
x, control; O, CaMA84; ■, CaMA83-84; □, CaMA81-84.
T a b le  II
Binding of the acrylodan-labeled peptide by bovine, control, and 
deletion calmodulins 
Kd values calculated from duplicate data sets were seen to vary by 
less than a factor of 2. Values for the acrylodan fluorescence emission 
maxima, Emissionmal, in the various complexes are also shown. Fur­
ther details of fitting procedures, peptide structure, and fluorescence 
measurements are presented under “Experimental Procedures.”
Calmodulin K / Kd Emissionmax
nM nm
Bovine 3.7 3.2 504
Control 3.9 4.0 506
CaMA84 25 32 504
CaMA83-84 13 12 508
CaMA81-84 17 18 508
“ Calculated using a weighted nonlinear curve-fitting procedure. 
























rescence anisotropy measured at various concentrations of 
added bovine or bacterial calmodulin are presented in Fig. 6. 
Standard deviations for the CaMA83-84 data set are also 
shown. Similar standard deviations were observed for the 
other calmodulin data sets but were not included in order to 
improve the clarity of the figure. As seen in Table II, calcu­
lated Kd values for bovine and control calmodulins are not 
significantly different, and all three deletions within the cen­
tral helix cause a 4-7-fold increase in Kd values. Similar 
differences were seen in Kd values estimated from calmodulin- 
dependent changes in acrylodan fluorescence intensity, meas­
ured at 490 nm (not shown).
DISCUSSION
Our observations indicate that residues Ser-81 through Glu- 
84 can be deleted from the solvent-exposed region in the 
central helix without greatly affecting calmodulin’s ability to 
interact with the targets we have evaluated. Relative to bac­
terial control values, Kmt values for NAD kinase and myosin 
light chain kinase are increased 5-7-fold, Kd values for binding 
of the peptide are increased 4-7-fold, and Kact values for 
calcineurin are increased only 2-3-fold. All these differences 
in Kact or Kd values are less than 1  order of magnitude, and 
Vm values for enzymes activated by the deletion proteins are 
all within 10-20% of control values. The parallel effects of 
the deletions on binding of skeletal muscle myosin light chain 
kinase and the synthetic peptide derived from its sequence 
support the previous localization of the calmodulin-binding 
domain in the kinase to a short peptide (Blumenthal et al., 
1985) represented by the synthetic one used in our studies.
Craig et al. (1987) have replaced the three glutamic acids 
encompassing residues 82-84 of the central helix with three 
lysines. This altered calmodulin is able to activate fully cal­
modulin-dependent cAMP phosphodiesterase activity, but it 
can elevate myosin light chain kinase activity to only 30% of 
the maximal level seen with a control protein and fails to 
activate NAD kinase activity. Kect values for both myosin 
light chain kinase and phosphodiesterase are increased about
2-fold relative to control values. Our results indicate that 
these effects of lysine substitutions reported by Craig et al. 
(1987) probably are not due to the elimination of contacts 
with residues in the glutamic acid cluster.
Interpretation of our results requires consideration of two 
very different levels at which the deletions affect calmodulin 
structure. The first is at the local level and involves alterations 
in specific side chain interactions in the region of the deleted 
residues. The second is at the global level and involves changes 
in the relative positions of the two calmodulin lobes. This 
latter effect arises because, as illustrated in Fig. 7, the dele­
tions are located in the solvent-exposed region of the central 
helix, where it bridges the two lobes. In a model in which the 
central helix is maintained, each deleted residue causes the 
two lobes of calmodulin to be twisted 100° relative to one 
another and brought 1.5 A closer together. In the functional 
assays we have performed there is little or no difference 
between CaMA84, which contains only a single amino acid 
deletion, and either CaMA83-84 or CaMA81-84. Therefore, 
the major effect of the deletions on calmodulin function can 
be attributed to removal of a single glutamic acid from the 
cluster: E82-E-E84. One of these residues may form a stabilizing 
electrostatic hydrogen bond with a residue in the target or in 
calmodulin itself. The presumed global structural changes 
associated with the deletions appear to have little effect on 
calmodulin’s ability to bind or activate the targets we have 
evaluated. If both lobes of calmodulin are required for for­
mation of complexes with these targets, then this means that
Fig. 7. Position of the deleted residues in the crystal struc­
ture of calmodulin. An tv-carbon tracing  of the  calm odulin crystal 
structure, which is currently  being refined in our laboratory, is p re ­
sented. T he C -term inal lobe of calm odulin is upperm ost, and the 
positions in th e  central helix of residues Ser-81 through Glu-84 are 
indicated.
in the calmodulin-target complex the lobes of all three dele­
tion proteins can adopt similar relative positions. This clearly 
requires some bending of the central helix, which would 
otherwise hold the lobes of each deletion protein in a different 
relative orientation. It is possible that targets interact with 
only one of calmodulin’s two lobes, so their relative positions 
are not important. While this cannot yet be ruled out with 
NAD kinase, published data suggest that interactions with 
several targets, including myosin light chain kinase, cAMP 
phosphodiesterase, and calcineurin, involve both lobes of cal­
modulin. If the two lobes are separated by trypsinolysis in the 
solvent-exposed region of central helix, they cannot activate 
myosin light chain kinase, cAMP phosphodiesterase, and 
calcineurin enzyme activities (Newton et al., 1984, 1985). 
However, if the fragments resulting from trypsinolysis are 
tethered by a chemical cross-link, their ability to activate 
enzymes is retained (Persechini and Kretsinger, 1988b). 
Klevit et al. (1985) have demonstrated that residues in both 
lobes of calmodulin are perturbed in the complex with a 
synthetic peptide based on the calmodulin-binding domain of 
skeletal muscle myosin light chain kinase. Furthermore, it is 
known that activation of both myosin light chain kinase and 
cAMP phosphodiesterase activities requires occupancy of all 
four Ca2+-binding sites in calmodulin (Blumenthal and Stull, 
1980; Huang et al., 1981).
Our results suggest that the central helix of calmodulin is 
bent in complexes between one or more of the deletion pro­
teins and the calmodulin targets we have evaluated. Perse­
chini and Kretsinger (1988b) have recently shown that this is 
probably also true for some native calmodulin-target com­
plexes. They have created a 16 A bismaleimidohexane cross­
link between cysteines substituted in calmodulin at positions 
3 and 146, which are 37 A apart in the crystal structure. 
Although this undoubtedly creates a bend in the central helix, 
it does not affect the ability of calmodulin to activate myosin 
light chain kinase activity. This indicates that in the native 
























helix is probably also bent, with the relative position of the 
two lobes different from that seen in the crystal structure. A 
model for this type of calmodulin-target complex has been 
proposed by Persechini and Kretsinger (1988a, 1988b). In 
their model the solvent-exposed region in the central helix 
functions as a flexible tether, and most contacts with the 
target involve residues in the two lobes of calmodulin. Hydro­
phobic patches associated with each lobe are juxtaposed with 
hydrophobic patches on the target. Given this type of model 
calmodulin-target complex, we might expect a degree of adapt­
ability to deletions or insertions within the central helix of 
calmodulin.
It is now well established that the entire sequence of cal­
modulin, including that of the central helix, is well conserved 
among a varied group of eucaryotic organisms, which repre­
sent millions of years of evolution (Manalan and Klee, 1984). 
Yet, we have shown that Ser-81 through Glu-84 can be deleted 
from the central helix with little effect on the calmodulin- 
target complexes we have evaluated. The effects that are 
observed can be attributed mostly to removal of a single 
glutamic acid, and presumed changes in the relative positions 
of the two lobes of calmodulin caused by the deletions appear 
to have minimal consequence on calmodulin function. How 
can these observations be reconciled with the conservation of 
primary structure seen in the central helix?
Stimulus-induced changes in intracellular Ca2+ ion are tran­
sient in nature, hence formation of Ca2+-calmodulin and 
subsequent activation of its targets are dynamic processes. It 
is, therefore, difficult to predict how small changes in in vitro 
steady state interactions, such as those we report here, might 
affect in vivo cellular function. Furthermore, we have assayed 
the abilities of the deletion proteins to activate only three of 
calmodulins more than 20 biological targets (Manalan and 
Klee, 1984). We might expect interactions with some of these 
targets to be more severely affected than others by the changes 
we have made in the central helix. Indeed, there is good 
evidence that contacts between calmodulin and its targets 
vary considerably among the different calmodulin-target com­
plexes (Craig et al., 1987; Manalan and Klee, 1984; Newton 
et al., 1984,1985).
While there are undoubtedly unique aspects to the inter­
actions between calmodulin and each of its targets, at a gross 
level there are essentially three possible classes of calmodulin- 
target complexes, which can be described in terms of the 
relative positions of the two lobes of calmodulin. In class I 
complexes the target interacts with only one lobe of calmo­
dulin or the other, so that the relative positions of the lobes 
are not important. In class II complexes there are interactions 
with both lobes of calmodulin, and their relative positions are 
close to what is found in the crystal structure. In class III 
complexes there are also interactions with both lobes of 
calmodulin, but they adopt relative positions different from 
what is observed in the crystal structure, most likely as a 
result of bending or distortion within the central helix of 
calmodulin. The targets we have evaluated in this study 
probably form class III complexes with calmodulin. However, 
as discussed elsewhere (Persechini and Kretsinger, 1988a), 
there are also examples of biological targets that appear to 
form class I complexes with calmodulin. Further definition of 
the various classes of calmodulin-target complexes is essential
if we are to understand structure-function relations in cal­
modulin and determine how it orchestrates so many different 
aspects of cellular function.
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